In this webinar, Dr Ian Dixon, Exopharm’s Managing Director and Founder, discusses three recent ASX announcements and answers questions in a Q&A facilitated by Paul Hart, Executive Director of Canary Capital.
The following ASX announcements are addressed:
01/04/2021 Preclinical Data from Osteoarthritis Animal Study
06/04/2021 Positive PLEXOVAL II Phase 1 Clinical Trial Results
06/04/2021 LEAP Technology- Advanced EV Medicines from Blood Components